Buck Martina, Chojkier Mario
Department of Medicine and Cancer Center, Veterans Healthcare Medical Center and University of California, San Diego, CA 92161, USA.
J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S295-9. doi: 10.1097/MCG.0b013e31814927d5.
To analyze the role of C/EBPbeta phosphorylation on hepatic stellate cell survival/cell death.
Activation and survival of stellate cells is critical for the development of liver fibrosis. C/EBPbeta phosphorylation regulates stellate cell survival by affecting caspase 8 activation. The mechanisms responsible for these effects are unknown.
We study the effects of caspase 8 activators signaling through death receptors. In addition, we assess the role of C/EBPbeta phosphorylation on the susceptibility of stellate cells to apoptotic stimuli. Finally, we investigated whether C/EBPbeta is associated with the caspase 8 complex protein FLIP, a critical inhibitor of caspase 8.
Primary mouse stellate cells from C/EBPbeta wild type and the phosphorylation mimic C/EBPbetaGlu transgenic mice were treated with lipopolysaccharide [an inducer of tumor necrosis factor-alpha (TNF-alpha)], FAS, or TNF-alpha. Stellate cell apoptosis was determined by assessing the binding of annexin-V to exposed phosphatidylserine of plasma membranes. TNF-alpha and FAS, but not lipopolysaccharide, induced annexin-V binding at 6 hours in C/EBPbeta wild type stellate cell. However, the stimulation of apoptosis by TNF-alpha and FAS was markedly blocked in C/EBPbetaGlu stellate cells (P<0.001). Stellate cells activated on a collagen type 1 matrix expressed both C/EBPbeta and FLIPL. Treatment of stellate cells with a MAP kinase kinase1 (MEK1) inhibitor blocked FLIPL cellular localization, suggesting that MEK1 signaling through C/EBPbeta modulates FLIP activity. The colocalization of C/EBPbeta and FLIPL was disrupted by activation of the FAS receptor, by blocking the association of C/EBPbeta with the long form of FLIP, FLIPL.
The MAPK-RSK-C/EBPbeta signaling may modulate stellate cell survival through caspase 8-associated protein FLIPL. This step is critical for liver fibrosis and if blocked with competitor peptides may prevent fibrogenesis.
分析C/EBPβ磷酸化在肝星状细胞存活/细胞死亡中的作用。
星状细胞的激活和存活对肝纤维化的发展至关重要。C/EBPβ磷酸化通过影响半胱天冬酶8的激活来调节星状细胞的存活。造成这些影响的机制尚不清楚。
我们研究了通过死亡受体发出信号的半胱天冬酶8激活剂的作用。此外,我们评估了C/EBPβ磷酸化对星状细胞对凋亡刺激敏感性的作用。最后,我们研究了C/EBPβ是否与半胱天冬酶8复合体蛋白FLIP相关,FLIP是半胱天冬酶8的关键抑制剂。
用脂多糖[肿瘤坏死因子-α(TNF-α)的诱导剂]、FAS或TNF-α处理来自C/EBPβ野生型和磷酸化模拟物C/EBPβGlu转基因小鼠的原代小鼠星状细胞。通过评估膜联蛋白-V与质膜暴露的磷脂酰丝氨酸的结合来确定星状细胞凋亡。TNF-α和FAS而非脂多糖在C/EBPβ野生型星状细胞中6小时诱导膜联蛋白-V结合。然而,在C/EBPβGlu星状细胞中,TNF-α和FAS对凋亡的刺激被显著阻断(P<0.001)。在I型胶原基质上激活的星状细胞同时表达C/EBPβ和FLIPL。用丝裂原活化蛋白激酶激酶1(MEK1)抑制剂处理星状细胞可阻断FLIPL的细胞定位,表明通过C/EBPβ的MEK1信号传导调节FLIP活性。FAS受体的激活、通过阻断C/EBPβ与长形式的FLIP即FLIPL的结合,破坏了C/EBPβ和FLIPL的共定位。
MAPK-RSK-C/EBPβ信号传导可能通过半胱天冬酶8相关蛋白FLIPL调节星状细胞存活。这一步骤对肝纤维化至关重要,如果用竞争性肽阻断可能预防纤维化形成。